Avik Majumdar

2.3k total citations
84 papers, 973 citations indexed

About

Avik Majumdar is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Avik Majumdar has authored 84 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 58 papers in Hepatology and 32 papers in Surgery. Recurrent topics in Avik Majumdar's work include Liver Disease and Transplantation (52 papers), Liver Disease Diagnosis and Treatment (52 papers) and Organ Transplantation Techniques and Outcomes (22 papers). Avik Majumdar is often cited by papers focused on Liver Disease and Transplantation (52 papers), Liver Disease Diagnosis and Treatment (52 papers) and Organ Transplantation Techniques and Outcomes (22 papers). Avik Majumdar collaborates with scholars based in Australia, United Kingdom and United States. Avik Majumdar's co-authors include Emmanuel Tsochatzis, Stuart K. Roberts, Matthew T. Kitson, Douglas Thorburn, Davide Roccarina, Kurinchi Selvan Gurusamy, Massimo Pinzani, Simone I. Strasser, Geoffrey W. McCaughan and Ken Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cochrane Database of Systematic Reviews.

In The Last Decade

Avik Majumdar

66 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avik Majumdar Australia 17 651 584 330 102 93 84 973
Deepak Gunjan India 20 551 0.8× 544 0.9× 400 1.2× 148 1.5× 93 1.0× 122 1.1k
Kaushal Madan India 18 544 0.8× 592 1.0× 559 1.7× 119 1.2× 59 0.6× 32 1.3k
Ying Peng China 16 750 1.2× 727 1.2× 331 1.0× 53 0.5× 37 0.4× 34 1.0k
Joseph K. Lim United States 10 551 0.8× 513 0.9× 316 1.0× 58 0.6× 38 0.4× 16 1.3k
Abhasnee Sobhonslidsuk Thailand 21 557 0.9× 652 1.1× 253 0.8× 27 0.3× 162 1.7× 66 1.1k
Marco Antonio Álvarez Spain 15 475 0.7× 524 0.9× 358 1.1× 107 1.0× 68 0.7× 40 1.2k
Manhal Izzy United States 15 576 0.9× 487 0.8× 339 1.0× 24 0.2× 58 0.6× 72 898
Chavdar S Pavlov Russia 18 455 0.7× 688 1.2× 179 0.5× 53 0.5× 72 0.8× 84 937
M. Salvagnini Italy 17 607 0.9× 576 1.0× 277 0.8× 125 1.2× 47 0.5× 34 1.1k
James Maurice United Kingdom 14 654 1.0× 962 1.6× 318 1.0× 37 0.4× 72 0.8× 38 1.3k

Countries citing papers authored by Avik Majumdar

Since Specialization
Citations

This map shows the geographic impact of Avik Majumdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avik Majumdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avik Majumdar more than expected).

Fields of papers citing papers by Avik Majumdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avik Majumdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avik Majumdar. The network helps show where Avik Majumdar may publish in the future.

Co-authorship network of co-authors of Avik Majumdar

This figure shows the co-authorship network connecting the top 25 collaborators of Avik Majumdar. A scholar is included among the top collaborators of Avik Majumdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avik Majumdar. Avik Majumdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urbancic, Karen, Gemma Reynolds, Sara Vogrin, et al.. (2025). Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program. Transplant Infectious Disease. 27(4). e70046–e70046.
2.
Cailes, B., E. Huber, Omar Farouque, et al.. (2025). Blunted cardiac reserve as a marker of cirrhotic cardiomyopathy—Cardiac outcomes following liver transplantation and comparison to the existing guidelines. American Journal of Transplantation. 25(9). 1976–1986. 1 indexed citations
3.
Cailes, B., Numan Kutaiba, Omar Farouque, et al.. (2025). Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients. Liver Transplantation. 31(12). 1522–1532.
4.
Chapman, Brooke, et al.. (2025). Real-World Experience of Home Continuous Terlipressin Infusion for Complications of Portal Hypertension. The American Journal of Gastroenterology.
5.
Cao, Jacob, Rachael Cordina, & Avik Majumdar. (2025). Unifying FALD assessment—A call to arms. Hepatology Communications. 9(9).
6.
Testro, Adam, et al.. (2025). The current applications and future directions of terlipressin. Hepatology Communications. 9(4). 1 indexed citations
7.
O’Sullivan, John, Giovanni Guglielmi, Eugene Slaughter, et al.. (2025). Plasma nicotinamide adenine dinucleotide pathway depletion is linked to diastolic dysfunction in patients with advanced chronic liver disease. Cardiovascular Research. 121(15). 2296–2298.
8.
Tran, Derek, et al.. (2024). Nutritional considerations for people living with a Fontan circulation: a narrative review. Cardiology in the Young. 34(2). 238–249. 3 indexed citations
9.
Read, Scott, et al.. (2024). Attitudes towards transjugular intrahepatic portosystemic shunt (TIPS) in Australia: a national survey of TIPS centres. BMJ Open Gastroenterology. 11(1). e001308–e001308. 2 indexed citations
10.
Cailes, B., A. Koshy, Avik Majumdar, et al.. (2024). Impaired Cardiac Reserve is a Novel Predictor of Major Adverse Cardiovascular Events After Liver Transplantation. Heart Lung and Circulation. 33. S127–S128.
11.
12.
McKenzie, Catriona, et al.. (2023). Banff 2016 Global Assessment and Quantitative Scoring for T Cell-Mediated Liver Transplant Rejection are Interchangeable. SHILAP Revista de lepidopterología. 2023. 1–7. 2 indexed citations
13.
Rockey, Don C., et al.. (2023). Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Alimentary Pharmacology & Therapeutics. 57(5). 454–463. 10 indexed citations
14.
George, Jacob, et al.. (2023). Evolution of risk prediction models for post-operative mortality in patients with cirrhosis. Hepatology International. 17(3). 542–545. 2 indexed citations
15.
Majeed, Ammar, Michael Bailey, William Kemp, et al.. (2022). Improved survival of cirrhotic patients with infections in Australian and New Zealand ICUs between 2005 and 2017. Liver International. 43(1). 49–59. 4 indexed citations
16.
Davis, Rebecca J., et al.. (2021). Prevalence and outcomes of Clostridioides difficile infection in liver transplant recipients. Transplant Infectious Disease. 24(1). e13758–e13758. 4 indexed citations
17.
Majumdar, Avik & Emmanuel Tsochatzis. (2020). Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. Metabolism. 111. 154291–154291. 23 indexed citations
18.
Majumdar, Avik, et al.. (2020). Metabolic associated fatty liver disease: Addressing a new era in liver transplantation. World Journal of Hepatology. 12(12). 1168–1181. 35 indexed citations
19.
20.
Onali, Simona, Maria Kalafateli, Avik Majumdar, et al.. (2017). Non‐selective beta‐blockers are not associated with increased mortality in cirrhotic patients with ascites. Liver International. 37(9). 1334–1344. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deepak Gunjan Breakdown of academic impact, for papers by Kaushal Madan Breakdown of academic impact, for papers by Ying Peng Breakdown of academic impact, for papers by Joseph K. Lim Breakdown of academic impact, for papers by Abhasnee Sobhonslidsuk Breakdown of academic impact, for papers by Marco Antonio Álvarez Breakdown of academic impact, for papers by Manhal Izzy Breakdown of academic impact, for papers by Chavdar S Pavlov Breakdown of academic impact, for papers by M. Salvagnini Breakdown of academic impact, for papers by James Maurice
Rankless by CCL
2026